000 01510 a2200421 4500
005 20250512203113.0
264 0 _c19840308
008 198403s 0 0 eng d
022 _a0300-8916
024 7 _a10.1177/030089168306900610
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLopez, M
245 0 0 _a5-Fluorouracil, adriamycin and cyclophosphamide combined with high-dose medroxyprogesterone acetate in advanced breast cancer.
_h[electronic resource]
260 _bTumori
_cDec 1983
300 _a545-51 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCyclophosphamide
_xadministration & dosage
650 0 4 _aDoxorubicin
_xadministration & dosage
650 0 4 _aDrug Evaluation
650 0 4 _aFemale
650 0 4 _aFluorouracil
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aMedroxyprogesterone
_xadministration & dosage
650 0 4 _aMedroxyprogesterone Acetate
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Metastasis
700 1 _aDi Lauro, L
700 1 _aPerno, C F
700 1 _aPapaldo, P
700 1 _aBarduagni, M
700 1 _aBarduagni, A
773 0 _tTumori
_gvol. 69
_gno. 6
_gp. 545-51
856 4 0 _uhttps://doi.org/10.1177/030089168306900610
_zAvailable from publisher's website
999 _c6229899
_d6229899